![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|39|9|525-533
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.39, Iss.9, 2016-08, pp. : 525-533
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia
Oncology Research and Treatment, Vol. 39, Iss. 1-2, 2016-0 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
State-of-the-Art First-Line Treatment of Ovarian Cancer
Oncology Research and Treatment, Vol. 26, Iss. 5, 2003-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
State-of-the-art thrombosis prevention and treatment
Therapy, Vol. 5, Iss. 2, 2008-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hypertension in the elderly: state‐of‐the‐art treatment
BJU INTERNATIONAL, Vol. 81, Iss. S1, 1998-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oncology, Vol. 86, Iss. 4, 2014-05 ,pp. :